US EditionPublished • loading... • Updated
Post-Vaccination SARS-CoV-2 IgG Antibody Titres in Retinal Vein Occlusion Patients: A Cross-Sectional Analysis
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Post-Vaccination SARS-CoV-2 IgG Antibody Titres in Retinal Vein Occlusion Patients: A Cross-Sectional Analysis
Purpose: The objective of the present study is to examine the levels of SARS-CoV-2 IgG antibody titres post COVID-19 vaccine in retinal vein occlusion (RVO) patients and in healthy control group; study conducted at the Regional Institute of Ophthalmology, Pt. B.D. ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
